PARSIPPANY, NJ--(Marketwire - February 04, 2009) - The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, February 18, 2009 at 8:30 a.m. Eastern Time to discuss fourth quarter and full year 2008 financial results, operational developments, guidance and outlook for 2009.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 800-901-5226 International Dial In: 617-786-4513 Passcode for both dial in numbers: 24685928
Replay is available from 11:30 a.m. Eastern Time following the conference call through March 4, 2009. To hear a replay of the call dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 28543782.
This call is being webcast and can be accessed at The Medicines Company website at www.themedicinescompany.com.
MDCO-G
The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU-2010, in early-stage development. The Company’s website is www.themedicinescompany.com.
Contact:
Robyn Brown
Vice President, Investor Relations
The Medicines Company
973-290-6000
Email Contact
